Checkpoint Therapeutics

Waltham, United States

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

$12.0M raised

Jul 2024

Post-IPO Equity

Biotechnology Health Care Oncology Pharmaceutical Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Checkpoint Therapeutics

How much funding has Checkpoint Therapeutics raised?

Checkpoint Therapeutics has raised $12.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2024.

Where is Checkpoint Therapeutics headquartered?

Checkpoint Therapeutics is headquartered in Waltham, United States.

What does Checkpoint Therapeutics do?

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

What stage is Checkpoint Therapeutics at?

Checkpoint Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 2, 2024.

MLA

"Checkpoint Therapeutics — Funding & Investors." VCBacked, July 2, 2024, https://www.vcbacked.co/company/checkpoint-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Checkpoint Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/checkpoint-therapeutics

Wikipedia (cite web)

{{cite web |title=Checkpoint Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/checkpoint-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 2, 2024.